Genvor Incorporated
GNVR
$1.95
-$0.05-2.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 60.27% | 86.98% | 151.08% | 97.13% | 373.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.88% | 86.33% | 146.19% | 93.43% | 474.47% |
| Operating Income | -64.88% | -86.33% | -146.19% | -93.43% | -474.47% |
| Income Before Tax | -53.46% | -76.72% | -126.97% | -68.97% | -325.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.46% | -76.72% | -126.97% | -68.97% | -325.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.46% | -76.72% | -126.97% | -68.97% | -325.06% |
| EBIT | -64.88% | -86.33% | -146.19% | -93.43% | -474.47% |
| EBITDA | -64.91% | -86.39% | -146.31% | -93.57% | -475.89% |
| EPS Basic | -40.45% | -63.33% | -110.84% | -63.43% | -363.06% |
| Normalized Basic EPS | -49.31% | -73.95% | -127.21% | -82.58% | -401.30% |
| EPS Diluted | -40.45% | -63.33% | -110.84% | -63.43% | -363.06% |
| Normalized Diluted EPS | -49.31% | -73.95% | -127.21% | -82.58% | -401.30% |
| Average Basic Shares Outstanding | 19.46% | 12.65% | 7.61% | 1.81% | -8.29% |
| Average Diluted Shares Outstanding | 19.46% | 12.65% | 7.61% | 1.81% | -8.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |